United States - English - NLM (National Library of Medicine)

a-s medication solutions - olmesartan medoxomil (unii: 6m97xtv3hd) (olmesartan - unii:8w1iqp3u10), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - olmesartan medoxomil 40 mg - benicar hct (olmesartan medoxomil and hydrochlorothiazide) is indicated for the treatment of hypertension, to lower blood pressure.  benicar hct is not indicated for the initial therapy of hypertension [see dosage and administration (2) ] . lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with benicar hct. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, su

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - olmesartan medoxomil (unii: 6m97xtv3hd) (olmesartan - unii:8w1iqp3u10) - olmesartan medoxomil 20 mg - benicar is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with benicar. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressu

Canada - English - Health Canada

laboratoire riva inc. - olmesartan medoxomil - tablet - 20mg - olmesartan medoxomil 20mg - angiotensin ii receptor antagonists

Canada - English - Health Canada

laboratoire riva inc. - olmesartan medoxomil - tablet - 40mg - olmesartan medoxomil 40mg - angiotensin ii receptor antagonists

Canada - English - Health Canada

angita pharma inc. - olmesartan medoxomil - tablet - 20mg - olmesartan medoxomil 20mg - angiotensin ii receptor antagonists

Canada - English - Health Canada

angita pharma inc. - olmesartan medoxomil - tablet - 40mg - olmesartan medoxomil 40mg - angiotensin ii receptor antagonists

Canada - English - Health Canada

accord healthcare inc - olmesartan medoxomil; hydrochlorothiazide - tablet - 20mg; 12.5mg - olmesartan medoxomil 20mg; hydrochlorothiazide 12.5mg - angiotensin ii receptor antagonists

Canada - English - Health Canada

accord healthcare inc - hydrochlorothiazide; olmesartan medoxomil - tablet - 12.5mg; 40mg - hydrochlorothiazide 12.5mg; olmesartan medoxomil 40mg - angiotensin ii receptor antagonists

Canada - English - Health Canada

accord healthcare inc - hydrochlorothiazide; olmesartan medoxomil - tablet - 25mg; 40mg - hydrochlorothiazide 25mg; olmesartan medoxomil 40mg - angiotensin ii receptor antagonists

Canada - English - Health Canada

glenmark pharmaceuticals canada inc. - olmesartan medoxomil - tablet - 20mg - olmesartan medoxomil 20mg - angiotensin ii receptor antagonists